Changes in Neuroplasticity Following Intensive Rehabilitation of Aphasia and/or Apraxia of Speech
NCT ID: NCT04604444
Last Updated: 2024-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2017-02-02
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT02094014
Effect of Participation in Virtual Exercise Sessions in Persons With Aphasia
NCT05455463
Predicting Language Recovery in Acute Stroke Patients in the Neurovascular Intensive Care Unit: An Exploratory Study With the Core Assessment of Language Processing.
NCT06817642
Clinic and Neurophysiology of Aphasia Treatment
NCT05572385
Links Between Motor Abilities and Language Ability Deficits in Patients With Post-stroke Aphasia
NCT05776368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multimodal Intensive Rehabilitation of Aphasia/AOS (MIRAA)
A minimum of 3 hour speech-language training daily during 10 days.
Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
Intensive Comprehensive Aphasia (ICAP) and Apraxia of Speech Program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multimodal Intensive Rehabilitation of Aphasia and Apraxia of Speech
Intensive Comprehensive Aphasia (ICAP) and Apraxia of Speech Program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Apraxia of Speech 7 months post stroke diagnosed by SLP
Exclusion Criteria
* Severe loss of sight
* Severe loss of hearing
* Metal implants (preventing fMRI)
* Claustrophobia (preventing fMRI)
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Malaga
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellika Schalling
Professor, Speech Language Pathologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellika Schalling, Professor
Role: PRINCIPAL_INVESTIGATOR
Uppsala University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uppsala Universitet
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/1651-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.